Infarction, Brain Terminated Phase 3 Trials for Ancrod (DB05099)

Also known as: Brain Infarction / Stroke NOS / Cerebral infarction / Cerebral infarct / Infarct cerebral

IndicationStatusPhase
DBCOND0125631 (Infarction, Brain)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00141011Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTreatment
NCT00300196ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic StrokeTreatment